News | November 01, 2006

Morbidity Linked to Anesthesia for Infrainguinal Bypass

While general endotracheal anesthesia (GETA) is the most common type of anesthesia used in infrainguinal bypasses, a study published in the November issue of the Journal of Vascular Surgery reveals that it may not be the best strategy.

“We analyzed CPT codes to trace clinical outcomes of various anesthesia options used in patients who underwent lower extremity infrainguinal bypasses: GETA, spinal anesthesia (SA) and epidural anesthesia (EA),” said Distinguished Fellow Anton N. Sidawy, MD, chief of surgical services at the Veterans’ Affairs Medical Center and Professor of surgery at George Washington and Georgetown Universities, in Washington, D.C. “We found that GETA was associated with worse 30-day morbidity including graft failure.”

Morbidity and mortality outcomes for each anesthesia type were compared using univariate analysis as well as multivariate logistic regression to control for confounders. Compared to SA, the odds of graft failure was 43 percent higher for GETA patients, but there was no statistically significant difference in the graft failure between those who had used EA and SA.

In addition, the odds of returning to the operating room, the incidence of cardiac events (postoperative myocardial infarctions or cardiac arrest) in patients who had no history of congestive heart failure or stroke, and the incidence of pneumonia were significantly higher in patients who had their procedure under GETA. However, there was no significant difference in 30-day mortality among the three groups in the study.
For more information, visitwww.vascularweb.org.

Related Content

Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery | May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology
News | Cardiovascular Surgery | May 01, 2017
ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
Overlay Init